Welcome back to Tufts in Translation where we will spotlight faculty advancing new therapeutic approaches, targets, platforms, and delivery systems. Sessions will feature early-stage research across the drug discovery and design landscape, with an emphasis on translational potential and industry relevance.

Krishna Kumar is Robinson Professor of Chemistry and Professor of Biomedical Engineering at Tufts University. He was Chair of the Department of Chemistry from 2006-2009 and then from 2012-2018. He is a Member of the Cancer Center at the Tufts Medical Center in Boston. He received his Ph.D. from Brown University in 1996 and after postdoctoral studies at the Scripps Research Institute joined Tufts in 1998. Kumar’s contributions to science, and in particular chemistry and medicine, have been recognized widely. He was named a DuPont Young Professor, recognized as one of the top 35 young innovators in the world by MIT Technology Review magazine (TR35), awarded a Global Indus Technovator award from MIT-IBC, is a recipient of the National Science Foundation CAREER award, Technology award from the Massachusetts Technology Transfer Center, Excellence in Chemical Sciences Award from the Indian Society for Chemistry and Biology. He was elected a Fellow of the American Association of the Advancement of Science (AAAS), elected Fellow of the Royal Society of Chemistry, elected Senior Member of the National Academy of Inventors and was recently the recipient of the Rao Makineni Award Lectureship of the American Peptide Society. His contributions to science range from the understanding the origin of life, peptide and protein design, medicinal chemistry, biophysics and cell and molecular biology. Recent work has focused on multi-agonists for metabolic syndrome that rival or better than the blockbuster compounds in the clinic.